Calcium Carbonate
| Drug Category | Drug | IHD Dosing |
Administration Timing Around HD Session |
|---|---|---|---|
| Metabolic Bone Disease Medications | Calcium Carbonate | Dose based on blood work | As a phosphate binder, administer with meals. As supplementation, administer post-HD |
|
Molecular Weight (Da) | Excreted Unchanged (%) | Normal Half-Life (Hours) | ESRD Half-Life (Hours) | Plasma Protein Binding (%) | Volume of Distribution (L/kg) | Dialytic Plasma Clearance (ml/min) | % Dialyzed |
|---|---|---|---|---|---|---|---|
| 100 | N/A | N/A | N/A | 40 | 99% (in bone), 1% in intra and extracellular fluids | N/A | N/A |
References:
- Bushinsky D, Monk R. Electrolyte quintet: Calcium. Lancet 1998; 352(9124), 306-11.
- DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL: http://www.drugbank.ca/drugs/DB06724
- Levenson D, Bockman R. A Review of Calcium Preparations. Nutrition 1994 ; 52(7), 221-232.